Cellevate: Funding, Investors & Team (Sep 2026)
Cellevate is a cutting-edge biotech firm dedicated to creating advanced cell culture systems for the future.
Cellevate has raised $3.6M across 1 funding round on record, the most recent a Seed of $3.6M announced in Oct 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cellevate Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Cellevate Funding Rounds
Cellevate Founders and Leadership Team
Contact details for the Cellevate team: 1 of 1 has an email address on file.
Start 14-day free trial →Cellevate Funding Compared to Other Biotechnology Startups
Cellevate's latest round of $3.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cellevate in Biotechnology and Lund
Companies Similar to Cellevate
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Cellevate Funding FAQs
What does Cellevate do?
Cellevate is a cutting-edge biotech firm dedicated to creating advanced cell culture systems for the future.
How much funding has Cellevate raised?
Cellevate has raised $3.6M across 1 round on record. The most recent is a Seed of $3.6M announced in Oct 2023.
When did Cellevate last raise funding?
Cellevate's most recent funding round on record is a Seed of $3.6M, announced in Oct 2023.
Who founded Cellevate?
FundedIQ lists Maximilian Ottosson (Founder) at Cellevate.
Where is Cellevate headquartered?
Cellevate is based in Lund, Skane Lan, Sweden.
How many employees does Cellevate have?
Cellevate is in the 11-50 employee band.
How does Cellevate's funding compare to other Biotechnology startups?
Cellevate's latest round of $3.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Cellevate Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cellevate is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.